Alfred T Sapse, MD(R) of Stem Cell Pharmaceuticals Announces the Forming of a Nevada Corporation -- Superstatins Pharmaceuticals(TM), Inc. (SSPI) on February 03, 2009

LAS VEGAS, NV--(Marketwire - February 03, 2009) - SSPI would deal with statins presently available on the market, their successes and limitations and the superstatins™ drugs that would dominate the world of medicine, now and in the future.

According with research on cortisol, carried out over the four decades, Dr. Sapse is summarizing the pharmacological action of statins and super statins as follows:

STATINS are inhibitors of the synthesis of endogenous cholesterol and weak cortisol modulators by minimally blocking the exogenous cholesterol, into becoming cortisol.

SUPER STATINS are inhibitors of the synthesis of endogenous cholesterol and powerful cortisol modulators by blocking the exogenous cholesterol into becoming cortisol.

Endogenous Cholesterol is cholesterol that is made inside the body by the liver.

Exogenous Cholesterol is cholesterol that is obtained outside of the body from foods and is usually obtained through diets high in cholesterol and saturated fats.

Cortisol is a hormone manufactured by the adrenal gland that is helping an individual cope with everyday stress, but becoming a deadly immune suppressor when manufactured in large amounts under the effect of chronic stress, as is the case with most diseases known to mankind today.

Cortisol Modulators are drugs that are controlling the wide variations of cortisol as found in diseases of all types, and taking them to a normal level thus bringing about clinical improvements ranging from modest to very impressive.

The wide arrays of diseases that can be potentially helped by the super statins are:

-- Neurodegenerative diseases: MS, Parkinson, ALS -- Diseases of aging: Alzheimer’s, macular degeneration (AMD) dry and wet. -- Diseases induced sometimes by excessive use of cortisone / cortisol drugs: Osteoporosis, Ulcers, Obesity Cataracts, Exema, Psoriazis, symptoms of Dementia, Hypertension -- Autoimmune: MS, Lupus Erythematosus (LE), Hashimoto’s, Retinitis Pigmentosa (RP) the only one auto-immune disease, where cortisol is manufactured in the eye (ectopic cortisol) and not by the adrenal gland. -- Cancers of all types. -- Sepsis, associated with very high levels of cortisol. -- Used before major surgery, which combined with the patient anxiety and general anesthesia are forming a very stressful combination that would jeopardize the outcome of the surgery. -- Super Statins can prevent an HIV positive, where cortisol is normal into sliding into full blown AIDS associated with high cortisol. -- Super statins can prevent the inactivation or destruction of stem cells, when implanted in an individual with a high cortisol disease. -- Super statins can reduce side effects affecting muscles. -- Super statins used in preventative medicine: The introduction of the super statins would open a practical approach to the preventative medicine where they would be used not in treating diseases, but in preventing them. -- Detailed explanations on each condition above will follow in subsequent news releases. 

SSPI’s technology can take a statin, any statin, and make it into a super statin, which when used in double blind studies won’t need the connotation “in association with...” because it would be that just the drug and the placebo ONLY.

Moreover, we believe that some of these double blind studies using super statins vs. placebo will be stopped and un-blinded because the results obtained would easily identify which one is the drug and which one is the placebo.

The strategy of the SSPI is to find a suitable partner that would allow us to commence one clinical study abroad preferably in the UK or Switzerland, obtain an approval for one claim only and perhaps later on in off labeling it.